Skip to content
Skip to product content
Purist Peptides BPC-157 + TB-500 Wolverine Stack vial - injury-recovery and tissue-repair peptide stack
Purist Peptides BPC-157 + TB-500 Wolverine Stack - injury-recovery and tissue-repair peptide stack overview
Purist Peptides BPC-157 + TB-500 Wolverine Stack vial - injury-recovery and tissue-repair peptide stack
Purist Peptides BPC-157 + TB-500 Wolverine Stack - injury-recovery and tissue-repair peptide stack overview

BPC-157 + TB-500 - WOLVERINE STACK

BPC-157 and TB-500 supplied in a single pre-mixed vial, 10mg of each — two repair-research peptides with non-overlapping mechanisms.

Mainly studied for:

  • Mechanism: BPC-157 is studied for angiogenic and nitric oxide signalling; TB-500 for G-actin sequestration and cell migration.
  • Studied for: Tissue-repair models where vascular supply and cell migration are examined together; no controlled study of the combination itself has been published.
  • Supplied as: Lyophilised powder, single 20mg vial at a fixed 1:1 ratio, independently HPLC assayed for both compounds.

No dosing protocol, cycle length or administration schedule is provided. Independently assayed by HPLC. Strictly for laboratory research use. Not for human or veterinary consumption.

R 1,600
Order in the next 0 hours 29 minutes to get it between Thursday, 17th March and Tuesday, 22nd March
Dosage guidelines ↗
Angiogenic signalling + actin-mediated cell migrationMechanism
10mg + 10mgPer vial
Lyophilised powder, single vialPresentation
Independently HPLC testedEvery batch

Overview

In plain English

The Wolverine Stack is BPC-157 and TB-500 supplied together — 10mg of each in a single lyophilised vial.

It is the most common pairing in the tissue-repair research category, because the two compounds are studied for different parts of the repair process rather than the same one: BPC-157 for blood supply into damaged tissue, TB-500 for the machinery cells use to migrate into it. Strictly for laboratory research use. Not for human or veterinary consumption.

  • What it isBPC-157 10mg + TB-500 10mg in one vial
  • Mainly studied forTissue-repair models where vascular supply and cell migration are both examined
  • Supplied asLyophilised powder, single 20mg vial at a fixed 1:1 mass ratio, independently assayed

How it works

What it actually does

Repair needs two things: blood reaching the damaged area, and repair cells physically moving into it.

BPC-157 is associated with the first — new blood vessel growth into tissue that normally has a poor supply. TB-500 is associated with the second — the internal machinery cells use to migrate.

The two do not share a pathway, which is the entire logic of the pairing. No controlled study of the combination itself has been published; the evidence sits with each compound separately.

BPC-157 molecular structure diagram — a constituent of the BPC-157 + TB-500 stack
The science in detail

The rationale for pairing these two compounds is mechanistic separation, not additive potency. They intervene at different points in the tissue repair sequence and, on current evidence, share no common pathway.

BPC-157 is a 15-residue fragment of a protein isolated from human gastric juice. No single high-affinity receptor has been identified for it. Its described actions are extracellular and vascular: Hsieh et al. (Journal of Molecular Medicine, 2017) associated its pro-angiogenic activity with activation and upregulation of VEGFR2 and downstream Akt–eNOS signalling, with the effect attenuated by VEGFR2 blockade. A second body of work describes bidirectional modulation of the nitric oxide system, with Hsieh et al. (Scientific Reports, 2020) reporting effects on vasomotor tone through a Src–caveolin-1–eNOS pathway. In connective tissue, Chang et al. (Journal of Applied Physiology, 2011) reported increased tendon fibroblast outgrowth, survival and migration in vitro. The functional theme is vascular supply and the extracellular signalling environment.

TB-500 is based on thymosin beta-4, the principal G-actin sequestering peptide in mammalian cells. It binds actin monomer in a 1:1 complex and holds it unpolymerised, creating a reservoir that permits rapid, localised F-actin polymerisation at the migrating cell's leading edge. The actin-binding activity localises to the LKKTETQ motif. Malinda et al. (Journal of Investigative Dermatology, 1999) reported accelerated dermal repair in rodent models; Bock-Marquette et al. (Nature, 2004) described a separate pathway through integrin-linked kinase activation in cardiac tissue. A further mechanism operates through liberation of the N-terminal tetrapeptide Ac-SDKP by prolyl oligopeptidase and meprin-α, which carries independent anti-fibrotic activity. The functional theme here is intracellular: cytoskeletal remodelling and cell motility.

One compound addresses whether cells can reach the site and whether it is perfused; the other addresses the machinery cells use to move. That non-overlap is the entire basis of the pairing.

Evidence

What the research shows

01

Two mechanisms, no overlap

One targets blood supply to the injury, the other targets how repair cells move into it.

02

Both evidence bases are animal-stage

Each compound has substantial preclinical work behind it and limited human trial data.

03

No study of the combination

The pairing is reasoned from the separate mechanisms, not from a trial of the two together.

04

Single vial, fixed ratio

One reconstitution yields a stock containing both compounds at a fixed 1:1 mass ratio set at manufacture.

Reconstitution & handling

Reconstitution and handling in the laboratory

These are general handling notes for the lyophilised peptide supplied by Purist Peptides. They describe the preparation of a stock solution for laboratory work. They are not a dosing protocol, and they describe no administration to a person or an animal.

A 3ml vial of bacteriostatic water is included free with every peptide vial you order, so the material can be reconstituted on arrival.

Wolverine Stack — BPC-157 10mg + TB-500 10mg — preparing a stock solution

Choice of diluent

Bacteriostatic water (water for injection with 0.9% benzyl alcohol) is the usual diluent where a stock will be drawn from repeatedly, because the preservative permits several septum entries across a working period. Sterile water for injection and sterile 0.9% sodium chloride are both used where a single-use preparation is wanted instead. The diluent volume sets the concentration of the stock, so record it.

Sterile technique

  1. Allow the sealed vial to reach room temperature before opening the carton — reconstituting a cold lyophilised cake slows dissolution
  2. Work in a clean area or a laminar flow cabinet, and wipe the rubber septum with 70% isopropyl alcohol, letting it dry fully
  3. Draw the chosen volume of diluent using a sterile single-use syringe and needle
  4. Angle the needle so the diluent runs down the inside wall of the vial — do not direct the stream onto the lyophilised cake
  5. Roll the vial gently between the palms until the cake has dissolved completely. Do not shake and do not vortex: peptides are surface-active, and agitation drives foaming and aggregation
  6. Let the vial stand for 5 to 10 minutes. A correctly reconstituted solution is clear and free of visible particles

Working out the concentration

Concentration follows from the mass in the vial and the volume of diluent added, nothing else. Adding 2ml of diluent to the vial gives a stock of 5mg/ml of each compound (10mg/ml total peptide); adding 1ml gives 10mg/ml of each. Label every reconstituted vial with its concentration and the date it was prepared.

Storage and stability

Before reconstitution

The lyophilised powder is the stable form. Sealed vials are best held at −20°C, protected from light and from moisture; the short periods at 2 to 6°C that occur in transit and on arrival are expected and are accounted for in the supply chain. Keep the vial in its carton — light and humid air are the two ordinary causes of loss on storage.

After reconstitution

Hold reconstituted solution at 2 to 6°C and protect it from light. Do not freeze a working stock: freeze-thaw cycling is the main avoidable cause of degradation and of visible precipitate. Where material must be held beyond a short working period, aliquot the stock into sterile low-binding tubes and freeze the aliquots once at −20°C or below, thawing each aliquot only once.

Checks before use

Inspect every vial against a light source. Discard any solution that is hazy, discoloured or contains particles, and any vial whose septum integrity is in doubt. The independent HPLC assay report for the batch supplied is available on request.

Strictly for laboratory research use. Not for human or veterinary consumption.

Four-step peptide reconstitution guide: bring the vial to room temperature, add bacteriostatic water down the vial wall, roll gently without shaking, and store refrigerated at 2 to 6 degrees Celsius without freezing

Ready to order — back to the top

Questions

Frequently asked questions

Is there research on the combination itself?

No controlled study of BPC-157 and TB-500 administered together has been published. The evidence base consists of separate preclinical work on each compound. The pairing is a research convention grounded in mechanistic non-overlap, not a validated protocol, and should be described as such.

Why are these two compounds paired?

Their mechanisms do not intersect. BPC-157's described actions are extracellular and vascular — VEGFR2-associated angiogenic signalling and modulation of nitric oxide. TB-500 acts intracellularly on the actin cytoskeleton, controlling the machinery of cell migration. Pairing them addresses two different constraints on tissue repair.

Do the two compounds need to be reconstituted separately?

No. The Wolverine Stack is supplied as a single pre-mixed lyophilised vial containing 10mg of each compound, so one reconstitution yields a stock containing both at a fixed 1:1 mass ratio. Add the diluent to the vial as supplied and follow the reconstitution notes above.

Why is it called the Wolverine Stack?

It is a colloquial name that circulated in research and forum communities, referring to the fictional character's rapid tissue repair. It carries no scientific meaning and implies nothing about the strength of the underlying evidence, which is preclinical.

How is purity verified?

Every batch is assayed by independent HPLC at Bioindustrial Services in Boksburg, and the assay covers both compounds in the vial. We do not rely on the manufacturer's own certificate alone. The assay reports for the batches you receive are available on request, and our full testing protocol is set out at Quality Standards.

How long does delivery take?

Orders are dispatched from South Africa, with timelines varying by region and courier. Current dispatch and transit windows are set out at Delivery Process.

Can I return an order?

Because these are laboratory compounds, returns are not accepted once an order has shipped. If your parcel arrives damaged, contact us within 48 hours with photographs of the packaging and product and we will arrange a replacement. The full terms are set out in our Refund Policy.

Ready to order BPC-157 + TB-500 - WOLVERINE STACK?

Independently assayed to 99%+ purity. Research use only.

Add to cart — R 1,600.00

The Purist Research Standard

Precision-engineered peptides designed to maintain structural integrity under rigorous laboratory conditions.

Optimized Logistics & Fulfillment

Our logistics and fulfillment protocols are engineered to prioritize research stability.

≥99% Research-Grade Purity

Every compound is synthesized to exceed a 99% purity threshold.

Third-Party Laboratory Verified

We maintain total transparency through independent COA.

Feature image

Precision Lyophilization Technology

Our advanced flash-freeze and vacuum-drying process.

Controlled Synthesis Environment

Produced in sterile, ISO-compliant facilities.

Targeted Research Utility

Engineered as reliable biological models.

Testimonials

Real feedback from customers who prioritize purity, precision, and uncompromising quality standards.

A few weeks into Tesamorelin and the
main thing I’ve noticed is deeper sleep. Waking up feeling properly rested again. Training recovery also seems a lot smoother.

The GHK-Cu has been interesting. Skin looks noticeably healthier and smoother, and a couple people even asked what I changed in my routine.

Tesamorelin seems to be doing exactly what I hoped it would. Sleep quality improved first, then I started noticing better recovery from hard training days.

With Glutathione I started noticing that my skin looked clearer and healthier overall. It wasn’t something I expected to see so quickly.

Tesamorelin has been a solid addition to my routine. Better sleep, better recovery and overall I feel more refreshed when waking up.

Since introducing DSIP. I fall asleep quicker and stay asleep through the night, which rarely used to happen.

Sleep depth improved quite a bit with Tesamorelin. Recovery between workouts feels smoother as well.

Energy levels during training have been very consistent since adding MOTS-C. Even during longer sessions the fatigue doesn’t build up the same way.

Cart (0)

10% OFF for your first order. Use code NEW10

You're R 3,000.00 away from FREE SHIPPING!

Your cart is currently empty

BPC-157

R 549

Melanotan II

R 400

CJC-1295 w DAC

R 1,200

DSIP

R 899

MOTS-C

TB-500

R 899

NAD+

R 1,399

Recently Viewed

BPC-157

R 549

Melanotan II

R 400

CJC-1295 w DAC

R 1,200

DSIP

R 899

MOTS-C

TB-500

R 899

NAD+

R 1,399